Premium
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management
Author(s) -
Cetani Filomena,
Pardi Elena,
Ambrogini Elena,
Lemmi Monica,
Borsari Simona,
Cianferotti Luisella,
Vignali Edda,
Viacava Paolo,
Berti Piero,
Mariotti Stefano,
Pinchera Aldo,
Marcocci Claudio
Publication year - 2006
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2006.02438.x
Subject(s) - men1 , germline mutation , primary hyperparathyroidism , proband , multiple endocrine neoplasia , hyperparathyroidism , medicine , parathyroidectomy , mutation , genetics , germline , gastroenterology , endocrinology , pathology , biology , gene , parathyroid hormone , calcium
Summary Objective Familial isolated primary hyperparathyroidism (FIPH) can result from either incomplete expression of a syndromic form of familial primary hyperparathyroidism [multiple endocrine neoplasia type 1 (MEN 1), hyperparathyroidism–jaw tumour syndrome (HPT‐JT) or familial hypocalciuric hypercalcaemia (FHH)] or still unrecognized causes. Design Genetic analyses of MEN1 , HRPT2 and CASR genes in FIHP. Patients Seven well‐characterized Italian kindreds with FIHP, with negative clinical features for MEN 1, HPT‐JT and FHH. The mean age (± SD) at diagnosis was 45 ± 17 years (range 18–70 years) in the probands and 42 ± 18 years (range 15–69 years) in the other affected subjects. Measurements Direct sequencing of germline DNA of the MEN1 , HRPT2 and CASR genes from probands. The region of interest was amplified in some family members. Results Germline MEN1 mutations were detected in three kindreds. Multiglandular involvement was found in all but one affected subject belonging to the three kindreds with MEN1 mutations. In these patients persistence/relapse of the disease was observed unless an extensive parathyroidectomy (excision of 3 1 / 2 glands) had been performed, with the exception of one patient, who is currently normocalcaemic 168 months after excision of two glands. No mutations of MEN1 , HRPT2 and CASR genes were identified in the remaining four families. Conclusions MEN1 genotyping appears worthwhile in FIHP families, as the finding of mutation(s) may predict multiglandular involvement and therefore have practical surgical implications, and prompt further investigation in the family, with the possibility of identifying new cases and beginning a programme of periodic surveillance for emergence of tumours in all carriers.